Safety profile of lutetium-177 in patients with impaired renal function: A retrospective analysis of adverse events in mCRPC treatment. Dr. Saylani highlighted that Lutetium-177 vipivotide tetraxetan ...

All of which means the pressure is on for agencies to contain risks while not hindering the speed of innovation. With this in ...

The Trump administration on Thursday intensified its sweeping efforts to shrink the size of the federal workforce, the nation ...

President Donald Trump plans to sign an executive order on Tuesday that would continue downsizing the federal workforce, ...

The findings are disappointing, but questions around intervention timing, patient population, and others remain to be ...